• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PARP1 enhances influenza A virus propagation by facilitating degradation of host type I interferon receptor

tetano

Editor, Senior Moderator
J Virol. 2020 Jan 8. pii: JVI.01572-19. doi: 10.1128/JVI.01572-19. [Epub ahead of print] [h=1]PARP1 enhances influenza A virus propagation by facilitating degradation of host type I interferon receptor.[/h]
Xia C[SUP]1,[/SUP][SUP]2[/SUP], Wolf JJ[SUP]2[/SUP], Sun C[SUP]3[/SUP], Xu M[SUP]3[/SUP], Studstill CJ[SUP]2[/SUP], Chen J[SUP]3[/SUP], Ngo H[SUP]2[/SUP], Zhu H[SUP]3,[/SUP][SUP]4[/SUP], Hahm B[SUP]5[/SUP].
[h=3]Author information[/h] 1 Department of Biotechnology, College of Life Science and Technology, Jinan University, Guangzhou, Guangdong, China. hahmb@health.missouri.edu xiachuan@jnu.edu.cn. 2 Departments of Surgery & Molecular Microbiology and Immunology, University of Missouri, Columbia, Missouri, USA. 3 Department of Biotechnology, College of Life Science and Technology, Jinan University, Guangzhou, Guangdong, China. 4 Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, NJ USA. 5 Departments of Surgery & Molecular Microbiology and Immunology, University of Missouri, Columbia, Missouri, USA. hahmb@health.missouri.edu xiachuan@jnu.edu.cn.

[h=3]Abstract[/h] Influenza A virus (IAV) utilizes multiple strategies to confront or evade host type I interferon (IFN)-mediated antiviral responses in order to enhance its own propagation within the host. One such strategy is to induce the degradation of type I IFN receptor 1 (IFNAR1) by utilizing viral hemagglutinin (HA). However, the molecular mechanism behind this process is poorly understood. Here, we report that a cellular protein, poly (ADP-ribose) polymerase 1 (PARP1), plays a critical role in mediating IAV HA induced degradation of IFNAR1. We identified PARP1 as an interacting partner for IAV HA through mass spectrometry analysis. This interaction was confirmed by co-immunoprecipitation analyses. Furthermore, confocal fluorescence microscopy showed altered localization of endogenous PARP1 upon transient IAV HA expression or during IAV infection. Knockdown or inhibition of PARP1 rescued IFNAR1 levels upon IAV infection or HA expression, exemplifying the importance of PARP1 for IAV-induced reduction of IFNAR1. Notably, PARP1 was crucial for the robust replication of IAV, which was associated with regulation of the type I IFN receptor signaling pathway. These results indicate that PARP1 promotes IAV replication by controlling viral HA-induced degradation of host type I IFN receptor. Altogether, these findings provide novel insight into interactions between influenza virus and the host innate immune response and reveal a new function for PARP1 during influenza virus infection.IMPORTANCE Influenza A virus (IAV) infections cause seasonal and pandemic influenza, which pose a devastating global health concern. Despite the availability of antivirals against influenza, new IAV strains continue to persist by overcoming the therapeutics. Therefore, much emphasis in the field is placed on identifying new therapeutic targets that can more effectively control influenza. IAV utilizes several tactics to evade host innate immunity, which include the evasion of antiviral type I interferon (IFN) responses. Degradation of type I IFN receptor (IFNAR) is one known method of subversion, but the molecular mechanism for IFNAR downregulation during IAV infection remains unclear. Here we have found that a host protein poly (ADP-ribose) polymerase 1 (PARP1) facilitates IFNAR degradation and accelerates IAV replication. The findings reveal a novel cellular target for the potential development of antivirals against influenza, as well as expand our base of knowledge regarding interactions between influenza and the host innate immunity.
Copyright ? 2020 American Society for Microbiology.


PMID: 31915279 DOI: 10.1128/JVI.01572-19
 
Back
Top Bottom